Literature DB >> 4524630

In vitro properties of leukocyte dialysates containing transfer factor.

M S Ascher, W J Schneider, F T Valentine, H S Lawrence.   

Abstract

The chief impediment to the precise biochemical identification of transfer factor and its mechanism of action has been the lack of a reproducible in vitro assay. We now report on a method by which dialysates containing transfer factor of proven in vivo potency can convert nonimmune lymphocytes to immune responsiveness in vitro, as reflected by antigen-triggered lymphocyte proliferation. However, "water-dialyzed transfer factor" (TF(D)) prepared for in vivo use by the conventional method of dialysis against large volumes of water exhibits diminished activity in vitro and is frequently toxic to lymphocyte cultures. This problem can be avoided by dialysis of transfer factor into tissue culture medium. When this precaution is taken, such "media-dialyzed transfer factor" (TF(DM)) causes nonimmune lymphocytes to respond to antigen by an increment of thymidine incorporation that ranges from 2 to 25 times that of such cells cultured with antigen alone. This response is generally observed only in the presence of those antigens to which the TF(DM) donor expresses delayed cutaneous reactivity and is distinguishable from nonspecific adjuvant effects.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4524630      PMCID: PMC388187          DOI: 10.1073/pnas.71.4.1178

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  BIOLOGICAL AND ULTRASTRUCTURAL STUDIES OF LEUCOCYTE FRACTIONS AS TRANSPLANTATION ANTIGENS IN MAN.

Authors:  F T RAPAPORT; J DAUSSET; J M CONVERSE; H S LAWRENCE
Journal:  Transplantation       Date:  1965-07       Impact factor: 4.939

2.  The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes.

Authors:  H S LAWRENCE
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

3.  An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy.

Authors:  W E Bullock; J P Fields; M W Brandriss
Journal:  N Engl J Med       Date:  1972-11-23       Impact factor: 91.245

4.  Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis.

Authors:  M L Schulking; W H Adler; W A Altemeier; E M Ayoub
Journal:  Cell Immunol       Date:  1972-04       Impact factor: 4.868

5.  The effect of transfer factor therapy on tumor immunity in alveolar soft part sarcoma.

Authors:  A F LoBuglio; J A Neidhart; R W Hilberg; E N Metz; S P Balcerzak
Journal:  Cell Immunol       Date:  1973-04       Impact factor: 4.868

6.  Transfer factor therapy in a patient with progressive primary tuberculosis.

Authors:  M E Whitcomb; R E Rocklin
Journal:  Ann Intern Med       Date:  1973-08       Impact factor: 25.391

Review 7.  Cell-mediated immunity.

Authors:  F T Valentine; H S Lawrence
Journal:  Adv Intern Med       Date:  1971

8.  Passive transfer of tuberculin reactivity in vitro.

Authors:  P Fireman; M Boesman; Z H Haddad; D Gitlin
Journal:  Science       Date:  1967-01-20       Impact factor: 47.728

9.  Cellular recognition by mouse lymphocytes in vitro. I. Definition of a new technique and results of stimulation by phytohemagglutinin and specific antigens.

Authors:  W H Adler; T Takiguchi; B Marsh; R T Smith
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

10.  Effect of transfer factor on lymphocyte function in anergic patients.

Authors:  C H Kirkpatrick; R R Rich; T K Smith
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

View more
  9 in total

1.  Inhibitory activity of medium-dialyzed transfer factor on lymphocyte blastogenesis.

Authors:  C Mueller-Eckhardt; R E Ritts
Journal:  Blut       Date:  1976-05

2.  [In-vitro studies with human transfer factor].

Authors:  H Rainer; K Moser
Journal:  Blut       Date:  1977-06

3.  Inhibition or augmentation of PHA-induced lymphocyte transformation by factors of calculated lymphoblastoid cell lines.

Authors:  M Pinto; A Mizrahi
Journal:  Experientia       Date:  1979-04-15

4.  Effects of human transfer factor on the migration of guinea-pig macrophages: is there an antigen-specific activity?

Authors:  I L Sargent; M R Salaman
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

5.  Stimulation of lymphocytes by antigen in microplate cultures; absence of an effect of transfer factor in vitro.

Authors:  T Ahern; C J Sanderson
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

6.  [Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)].

Authors:  C P Sodomann; G Maerker-Alzer; K Havemann; C Dienst; H Schultz; D Mitrenga; K Schumacher; G A Martini
Journal:  Klin Wochenschr       Date:  1979-09-03

7.  An investigation into the antigen-specificity of transfer factor in its stimulatory action on lymphocyte transformation.

Authors:  M R Salaman
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

8.  Guinea pig transfer factor-like activity detected in vitro.

Authors:  W Dunnick; F H Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

9.  Requirement of precommitted cells as targets for the augmentation of lymphocyte proliferation by leukocyte dialysates.

Authors:  L Cohen; R S Holzman; F T Valentine; H S Lawrence
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.